Nintedanib
Nintedanib · NINTEDANIB 150 mg/1 · Capsule · Catalent Germany Eberbach GmbH
NDC 55361-0021-01 · 2 BAG in 1 BOX / 5000 CAPSULE in 1 BAG · DRUG FOR FURTHER PROCESSING · View full market →
Bulk ingredient — not a finished product
This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.
Medicare Part D
This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Nintedanib (Capsule)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| AvKARE | NINTEDANIB ESYLATE 150 mg/1 | Jul 23, 2026 | Sep 3, 2026 |
| AvKARE | NINTEDANIB ESYLATE 100 mg/1 | Jul 23, 2026 | Sep 3, 2026 |
| Apotex Corp. | NINTEDANIB ESYLATE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Apotex Corp. | NINTEDANIB ESYLATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | NINTEDANIB ESYLATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | NINTEDANIB ESYLATE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Catalent Germany Eberbach GmbH | NINTEDANIB 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Catalent Germany Eberbach GmBH | NINTEDANIB 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Cipla USA Inc. | NINTEDANIB ESYLATE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Cipla USA Inc. | NINTEDANIB ESYLATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Dr. Reddy's Laboratories Inc. | NINTEDANIB ESYLATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Dr. Reddy's Laboratories Inc. | NINTEDANIB ESYLATE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Edenbridge Pharmaceuticals LLC. | NINTEDANIB ESYLATE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Edenbridge Pharmaceuticals LLC. | NINTEDANIB ESYLATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Epic Pharma Llc | NINTEDANIB ESYLATE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Epic Pharma Llc | NINTEDANIB ESYLATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Exelan Pharmaceuticals Inc. | NINTEDANIB ESYLATE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Exelan Pharmaceuticals Inc. | NINTEDANIB ESYLATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Glenmark Pharmaceuticals Inc., USA | NINTEDANIB ESYLATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Glenmark Pharmaceuticals Inc., USA | NINTEDANIB ESYLATE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Golden State Medical Supply, Inc. | NINTEDANIB ESYLATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Golden State Medical Supply, Inc. | NINTEDANIB ESYLATE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sandoz Inc | NINTEDANIB ESYLATE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sandoz Inc | NINTEDANIB ESYLATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Nintedanib — NDC 55361-0021-01," retrieved September 3, 2026, https://drugdashboards.com/drug/55361002101.
Free to cite with attribution — see how the data is put together.